Table 2.
Frequencies of combination metastasis and 3, 5-y OS.
| Number (%) | 3-y OS | 5-y OS | Median OS (months) | |
|---|---|---|---|---|
| One site | ||||
| Only Lung | 2796 (26.86) | 9.05% | 1.54% | 11 |
| Only Bone | 1719 (16.51) | 10.99% | 2.27% | 12 |
| Only Liver | 534 (5.13) | 6.74% | 0.75% | 5 |
| Only Brain | 219 (2.10) | 7.76% | 1.37% | 9 |
| Two sites | ||||
| Bone and brain | 97 (0.93) | 2.06% | 0 | 5 |
| Bone and liver | 232 (2.22) | 3.45% | 0 | 4 |
| Bone and lung | 1126 (10.82) | 4.62% | 0.44% | 6 |
| Brain and liver | 23 (0.22) | 0 | 0 | 3 |
| Brain and lung | 337 (3.24) | 3.56% | 0.30% | 6 |
| Liver and lung | 641 (6.16) | 2.18% | 0.16% | 4 |
| Three sites | ||||
| Bone and brain and liver | 12 (0.12) | 0 | 0 | 3 |
| Bone and brain and lung | 221 (2.12) | 1.81% | 0 | 4 |
| Bone and liver and lung | 422 (4.05) | 1.81% | 0 | 3 |
| Brain and liver and lung | 79 (0.76) | 1.27% | 0 | 3 |
| Four sites | ||||
| Bone and brain and liver and lung | 91 (0.87) | 0 | 0 | 3 |
OS: overall survival.